Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Tempus AI Inc a technology company leading the adoption of AI to advance precision medicine and patient care today announced multiyear strategic collaborations with AstraZenecaand Pathos AI Inc
This clinical trial is a singlearm multicenter openlabel Phase II registration study to evaluate the efficacy safety and tolerability of savolitinib in treating gastric cancer or gastroesophageal jun
Charles River Laboratories International Inc ahead of the American Association for Cancer Research AACR Annual Meeting in Chicago IL has announced updates to its comprehensive portfolio of products and services supporting
FUJIFILM Diosynth Biotechnologies a worldleading contract development and manufacturing organization CDMO for biologics vaccines and advanced therapies today announced a year manufacturing supply agreement
Docquity Southeast Asias largest community of healthcare professionals HCPs and global biopharmaceutical leader AstraZeneca developed OAZisCare an endtoend patient support program PSP that improves cancer care and enhanced Respiratory Syncytial Virus...
Sichuan KelunBiotech Biopharmaceutical Co Ltd announced that the Company has been granted the clearance of investigational new drug IND application to initiated the clinical study of its potential firstinclass innovative ADC drug SKB
Rona Therapeutics a biotechnology company pioneering innovative RNAtargeted therapies announced that the Investigational New Drug IND application for RN a small interfering RNA siRNA drug targeting angiotensinogen AGT
Jazz Pharmaceuticals plc today announced the successful completion of its acquisition of Chimerix Inc Chimerix for approximately million in cash Chimerix is now a wholly owned subsidiary of Jazz
DAAN Biotherapeutics a leading innovative drug development company specializing in TCell receptor TCRbased therapies has signed an exclusive licensing agreement with GC Cell a gene and cell therapy firm for the tumor antigenspecific antibody sequence
WuXi Biologics a leading global Contract Research Development and Manufacturing Organization CRDMO announced the successful completion of the first commercial project Process Performance Qualification PPQ campaign
